Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2026
Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's DiseaseTzi Shin Toh, Lei Cheng Lit, Shen-Yang Lim, et al.
NPJ Parkinson'S Disease|January 9, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cellsYahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
Acta Neuropathologica|June 14, 2021
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsYing Fan, Raja S Nirujogi, Alicia Garrido, et al.
Science Translational Medicine|August 30, 2023
A blood-based marker of mitochondrial DNA damage in Parkinson's diseaseRui Qi, Esther Sammler, Claudia P Gonzalez-Hunt, et al.
NPJ Parkinson'S Disease|February 23, 2025
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variantShen-Yang Lim, Tzi Shin Toh, Jia Wei Hor, et al.
Medrxiv : the Preprint Server for Health Sciences|March 26, 2024
Understanding monogenic Parkinson's disease at a global scaleJohanna Junker, Lara M Lange, Eva-Juliane Vollstedt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2024
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global ScaleJohanna Junker, Lara M Lange, Eva-Juliane Vollstedt, et al.
NPJ Parkinson'S Disease|November 18, 2025
LRRK2 p.G2385R and p.R1628P variants in a multi-ethnic Asian Parkinson's Cohort: epidemiology and clinical insightsJun Wen Goh, Jia Lun Lim, Tzi Shin Toh, et al.
NPJ Parkinson'S Disease|June 20, 2025
A community-led initiative to de-risk and advance Parkinson's disease therapeutic targetsAlexandra Vaiana, Jonathan Behr, Ryan Birol, et al.
Plos One|October 3, 2023
Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease ProjectEva-Juliane Vollstedt, Harutyun Madoev, Anna Aasly, et al.
Pageof 4